People often wonder if combining medication with lifestyle changes is the best way to manage health conditions. One area of interest is the use of GLP-1 receptor agonists along with lifestyle modifications. These medications are commonly used to manage type 2 diabetes and obesity. They work by mimic
People with type 2 diabetes often take special medicines. Two of these are GLP-1 receptor agonists and SGLT2 inhibitors. Both help control blood sugar. But do they affect the risk of leg amputations differently? A big study looked at this question. It compared new users of these two types of drugs.
Bariatric surgery has been a top choice for tackling obesity. It offers substantial and lasting weight loss. For instance, procedures like sleeve gastrectomy and gastric bypass have shown impressive results. After a decade, these surgeries can lead to a total weight loss of 23. 4% and 26. 9%, respec
GLP-1 is a hormone that your body makes. It is released by special cells in your gut. This hormone has a big job: it helps your body release insulin, which in turn lowers blood sugar levels and can lead to weight loss. It does this by making you feel full and reducing your appetite. Scientists have
GLP-1 receptor agonists are drugs used to manage weight and diabetes. These drugs are used daily to help people lose weight. They are called glucagon-like peptide-1 receptor agonists. The drugs are not a quick fix. They have to be used consistently for them to work. This is called adherence and is
